Skip directly to content

On December 13, 2017, TAG participated in a hearing in Geneva, Switzerland to brief members of the Human Rights Council on human rights concerns in the United Arab Emirates (UAE). The meeting was held in preparation for the UAE’s Universal Period Review (UPR), a mechanism by which the human rights record of each United Nations member state is reviewed by other countries every five years.  

Civil society organizations can submit information to the HRC and put forward recommendations for how the country under review can better respect its human rights obligations as established by the Universal

On October 12, 2017, in Guadalajara, Mexico, Treatment Action Group, Advanced Access & Delivery, Harvard Medical School, Partners In Health, and the Stop TB Partnership sponsored a symposium in conjunction with the Union World Conference on Lung Health.

Introduction - Erica Lessem (Treatment Action Group) and Eloisa "Louie" Zepeda-Teng (TB meningitis survivor, the Philippines)

 

Remarks - Dr. Lucica Ditiu (Stop TB Partnership)

 

Panel 1: Perceptions of Risk - Dr. Cesar Bonilla (formerly of National TB Program, Perú), Dr.  Aamir Khan (Interactive Research & Development, Pakistan), Dr.

HIV Cure Research Information Sheet

December 2017

HIV Cure Research Status: Quick Summary

  • One person, Timothy Ray Brown, is considered cured, and there are several other documented cases where HIV viral load did not rebound for an extended period after an ART interruption (referred to as remission)
  • These outcomes remain rare and resulted from exceptional circumstances—stem cell transplants for HIV-positive people with cancers or extremely early initiation of ART—but they are providing important clues to researchers working to develop a cure
  • There are more numerous—but still relatively rare—examples of individuals who have

NEWS ON THE FIGHT TO END HIV/AIDS, VIRAL HEPATITIS, AND TUBERCULOSIS

TAGline Fall 2017

EVERYBODY IN, NOBODY OUT

Arguments favoring universal health care (UHC) are easy. Achieving political consensus as to the best strategy to achieve this is considerably more vexing. This is particularly true in the U.S., where the Affordable Care Act (ACA) patchwork of legislation and regulations has faced a barrage of executive and legislative attacks since the beginning of the year. And although the ACA and expansion of Medicaid in 32 states represents the closest the U.S.

Fall 2017 TAGline

December 2017

EVERYBODY IN, NOBODY OUT
By Tim Horn

Arguments favoring universal health care (UHC) are easy. Achieving political consensus as to the best strategy to achieve this is considerably more vexing. This is particularly true in the U.S., where the Affordable Care Act (ACA) patchwork of legislation and regulations has faced a barrage of executive and legislative attacks since the beginning of the year. And although the ACA and expansion of Medicaid in 32 states represents the closest the U.S.

Houston EtE Plan Timeline

on Mon, 12/04/2017 - 14:47

Step-by-step progress of the Houston End the Epidemic plan 

Date: 
Monday, December 4, 2017

By Tim Horn

Arguments favoring universal health care (UHC) are easy. Achieving political consensus as to the best strategy to achieve this is considerably more vexing. This is particularly true in the U.S., where the Affordable Care Act (ACA) patchwork of legislation and regulations has faced a barrage of executive and legislative attacks since the beginning of the year. And although the ACA and expansion of Medicaid in 32 states represents the closest the U.S.

How U.S. southern states are moving ahead without full health care coverage

By Jeremiah Johnson & Kenyon Farrow

Activists and health departments around the country continue to advance strategies to ‘End the Epidemic’ (EtE) in their jurisdictions, yet a central question remains. Are these ambitious plans appropriate in all U.S. jurisdictions, particularly given uneven access to health care systems?

What does the research tell us? 

By Richard Jefferys

After a long period during which HIV incidence rates seemed distressingly immutable, the last few years have seen a rapid accumulation of evidence that pre-exposure prophylaxis (PrEP) and HIV viral load suppression by antiretroviral therapy (ART) can dramatically reduce transmission risk. The effects of these interventions are now beginning to manifest at the population level, with reports emerging of declining HIV incidence in a number of different settings.

Pages